Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in OCGN — Ocugen, Inc.

CIK 1692234 Seattle, WA
Back to OCGN Full portfolio

Position in OCGN

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$42,578
+$41,635 QoQ
Shares Held
27,829
+5241.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#83
of 147 holders
Holding Since
Sep 2021
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in OCGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. OCGN ranks #234 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 336,990 $167,393,033
2 REGN
Regeneron Pharmaceuticals, Inc.
 230,151 $143,508,345
3 RPRX
Royalty Pharma plc
 1,694,250 $94,996,587
4 INCY
Incyte Corp
 425,616 $48,247,822
5 ALNY
Alnylam Pharmaceuticals, Inc.
 158,228 $47,631,369
6 BMRN
Biomarin Pharmaceutical Inc
 783,148 $44,811,725
7 LGND
Ligand Pharmaceuticals Inc
 120,304 $38,026,888
8 PTCT
Ptc Therapeutics, Inc.
 418,025 $34,098,295

All Filings in OCGN

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $42,578 27,829
2026-03-31 $943 521
2025-12-31 $675 500
2025-09-30 $815 500
2024-09-30 $3,150 3,176
2023-03-31 $240 282
2022-12-31 $5,907 4,544
2022-09-30 $8,088 4,544
2022-06-30 $13,490 5,943
2022-03-31 $19,611 5,943
2021-12-31 $27,040 5,943
2021-09-30 $228,151 31,776